Inventor · disambiguated record
Silvano Piani
Also filed as: PIANI SILVANO
10 granted patents·222 citations·filing 1980–1996
90Inventor score
Top patents by PatentIndex Score
10 records- 0189US5010063AHeparin derivatives and process for their preparationALFA WASSERMANN SPA·Filed 1989·Granted Apr 23, 1991·84 cites·14 claims
- 0282US5104860AHeparin derivatives and process for their preparationALFA WASSERMANN SPA·Filed 1990·Granted Apr 14, 1992·43 cites·13 claims
- 0372US4350627ABiologically active peptidesERBA FARMITALIA·Filed 1980·Granted Sep 21, 1982·33 cites·131 claims
- 0466US5639744ABile acids derivatives useful in the therapy of the biliary calculosis from cholesterol and of the pathologies caused by cholestasisALFA WASSERMANN SPA·Filed 1995·Granted Jun 17, 1997·20 cites·15 claims
- 0566US5430133ASemi-synthetic glycosaminoglycans with heparin or heparan structure of α-L-iduronic-2-O-sulfate acid modified in position 2ALFA WASSERMANN SPA·Filed 1993·Granted Jul 4, 1995·18 cites·27 claims
- 0656US5410039AProcess for the synthesis of glycosaminoglycans containing α-L-galacturonic acid substituted with nucleophilic groups in position 3ALFA WASSERMANN SPA·Filed 1994·Granted Apr 25, 1995·12 cites·8 claims
- 0746US5663389A3,4-Dihydro-2-iodomethyl-2,5,7,8-tetramethyl-2H-1-benzopyransALFA WASSERMANN SPA·Filed 1996·Granted Sep 2, 1997·3 cites·1 claims
- 0838US5405949AProcess for the synthesis of glycosaminoglycans with heparin or heparan structure modified in position 2 of the α-L-iduronic-2-O-sulfate acidALFA WASSERMANN SPA·Filed 1994·Granted Apr 11, 1995·4 cites·8 claims
- 0935US5446152AHeterocyclic compounds active in gastro-intestinal pathologiesALFA WASSERMANN SPA·Filed 1994·Granted Aug 29, 1995·2 cites·12 claims
- 1033US5608084ALactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosisALFA WASSERMANN SPA·Filed 1995·Granted Mar 4, 1997·3 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Silvano Piani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →